| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $253,982,143 ) (Continued on the next page) |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HL164710 | The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia | 001 | 2 | NIH | 6/25/2024 | $60,205 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | K12HD052896 | Child Health Research Career Development Award (CHRCDA) Program (K12) | 003 | 17 | NIH | 4/18/2024 | $0 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01NS125265 | Pediatric Chronic Headache and COVID-19: Use of Machine Learning and Biobehavioral Analysis to Classify Headache Mechanism and Optimize Treatment Course. | 000 | 3 | NIH | 5/22/2024 | $523,414 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01AG071858 | Integrated Platform to study Neurodegeneration in Alzheimer’s Disease | 000 | 4 | NIH | 4/18/2024 | $778,347 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HD114338 | Developing novel MR tools to optimize surgical planning and fetal outcome in TTTS | 000 | 1 | NIH | 7/26/2024 | $735,973 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01DC021469 | Structure and Function of Mechanosensitive Channels in Inner Ear Hair Cells | 000 | 1 | NIH | 6/6/2024 | $446,199 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01LM014300 | Real-time Monitoring and Correction of Clinical Decision Support Systems to Reduce Health Disparities | 000 | 1 | NIH | 8/21/2024 | $729,821 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01DK138023 | Leveraging glycan-metabolite interactions to shape structure and function of the gut microbiome | 000 | 1 | NIH | 7/5/2024 | $663,173 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01NS117626 | Targeted Delivery of Therapeutics into Motor Neurons for Post-exposure Treatment of Botulism | 000 | 4 | NIH | 7/25/2024 | $699,180 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R18HS029346 | Re-engineering Patient and Family Communication to Improve Diagnostic Safety Resilience | 000 | 3 | AHRQ | 8/19/2024 | $997,021 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HL131729 | Activation trajectories of integrin α5β1 | 001 | 8 | NIH | 6/14/2024 | $58,744 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | K12HD052896 | Child Health Research Career Development Award (CHRCDA) Program (K12) | 002 | 17 | NIH | 11/30/2023 | $444,599 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HL163937 | CMYA5 regulation of cardiac dyad structure and function | 000 | 2 | NIH | 11/28/2023 | $548,110 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | K99HL170075 | Identification of Novel Epigenetic Regulators of lymphocyte Development | 000 | 2 | NIH | 8/5/2024 | $154,138 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | RC2DK131963 | Generation of a temporal, spatial, and molecular map of in situ hematopoiesis | 000 | 3 | NIH | 6/18/2024 | $931,458 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01CA196703 | Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma | 001 | 9 | NIH | 4/17/2024 | $21,018 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01AG088082 | Role of clonal somatic mutations in microglia and Alzheimer’s disease | 000 | 1 | NIH | 8/19/2024 | $903,172 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01DK130836 | Microbial reactivation of sex steroids and visceral pain | 000 | 3 | NIH | 5/15/2024 | $556,072 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01LM013486 | Transfer Learning for Digital Curation of the EMR Clinical Narrative | 000 | 4 | NIH | 5/22/2024 | $376,125 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01CA265726 | Selective pressures from inherited variation impacting myeloproliferative neoplasm initiation | 000 | 3 | NIH | 6/12/2024 | $482,599 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HL131729 | Activation trajectories of integrin α5β1 | 000 | 8 | NIH | 1/10/2024 | $660,873 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | U01MH136558 | TransHealthGUIDE: Transforming Health for Gender-Diverse Young Adults Using Interventions to Drive Equity | 003 | 3 | NIH | 9/7/2024 | $1,344,044 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HD101421 | Skeletal Health and Bone Marrow Composition Among Youth | 000 | 5 | NIH | 3/26/2024 | $481,583 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | K08AR078370 | Translating Human Height Genetics to Skeletal Biology by Functional Genomics of the Growth Plate | 000 | 4 | NIH | 5/1/2024 | $173,340 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HD101421 | Skeletal Health and Bone Marrow Composition Among Youth | 002 | 5 | NIH | 5/7/2024 | $0 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HD101421 | Skeletal Health and Bone Marrow Composition Among Youth | 001 | 5 | NIH | 5/1/2024 | $48,159 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01CA196703 | Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma | 000 | 9 | NIH | 2/19/2024 | $378,338 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | T32NS007473 | Developmental Neurology | 001 | 24 | NIH | 7/26/2024 | $0 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R35CA232115 | Role of the Epitranscriptome in Cancer | 000 | 6 | NIH | 8/1/2024 | $1,008,900 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | T32NS007473 | Developmental Neurology | 000 | 24 | NIH | 7/22/2024 | $491,730 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01DK135707 | Isoform- and Sex-Specific Functions of CGRP in Gastrointestinal Motility | 000 | 2 | NIH | 5/8/2024 | $633,470 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | H1740188 | Healthy Tomorrows Partnership for Children Program | 02 | 4 | HRSA | 6/4/2024 | $32,925 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01EY024963 | RORalpha mediates chronic subretinal inflammation associated with AMD | 000 | 8 | NIH | 5/31/2024 | $507,705 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | P50MH112491 | Neural-immune Mechanisms and Synaptic Connectivity in Psychiatric Illness | 002 | 8 | NIH | 7/15/2024 | $3,248,788 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R21HD112697 | Does Altered Brain Connectivity Correlate with Developmental Outcomes and Executive Function in Congenital Heart Disease? | 000 | 1 | NIH | 6/24/2024 | $223,224 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R24AI162637 | Severe Chronic Neutropenia International Registry | 001 | 3 | NIH | 7/30/2024 | $1,122,390 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HL172489 | In vivo hematopoietic stem cell genetic modification by viral particles | 000 | 1 | NIH | 9/9/2024 | $889,998 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | K00MH133546 | Role of glycosylation in environmental and genetic schizophrenia risk | 000 | 3 | NIH | 12/5/2023 | $86,065 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | H1740188 | Healthy Tomorrows Partnership for Children Program | 00 | 4 | HRSA | 1/31/2024 | $17,075 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | H1740188 | Healthy Tomorrows Partnership for Children Program | 01 | 4 | HRSA | 2/2/2024 | $0 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | U01HL098147 | Genomic Effects on Right Ventricular Function, Clinical Features and Outcomes in CHD | 000 | 16 | NIH | 7/18/2024 | $479,711 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01NS134948 | Paradoxical Sensory Responses: A Clue Towards Understanding Biotypes in Autism Spectrum Disorder and Other Neurodevelopmental Disorders (R01 Diversity Supplement - Rogers) | 001 | 1 | NIH | 6/29/2024 | $51,278 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01NS134948 | Paradoxical Sensory Responses: A Clue Towards Understanding Biotypes in Autism Spectrum Disorder and Other Neurodevelopmental Disorders (R01 Diversity Supplement - Rogers) | 002 | 1 | NIH | 7/3/2024 | $51,470 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01NS121334 | Fetal Brain MRI as a Predictor of Late Neurodevelopmental Outcome in Congenital Heart Disease | 000 | 3 | NIH | 12/28/2023 | $420,029 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01NS124879 | Developmentally Programmed Remodeling of Apical ECM | 000 | 3 | NIH | 11/7/2023 | $393,522 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01AG071326 | Defining the Role of Poly ADP-ribose in Biomolecular Condensation in ALS and FTLD | 000 | 2 | NIH | 7/26/2024 | $654,638 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01EY034135 | The trigeminal nociceptive-pain pathway in pediatric mTBI: peripheral and central contributions to photophobia | 003 | 2 | NIH | 7/15/2024 | $492,782 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R21AR082609 | Conditional mouse models with dominant negative Osteogenesis Imperfecta | 001 | 2 | NIH | 5/23/2024 | $13,629 |
| | 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R21AR082609 | Conditional mouse models with dominant negative Osteogenesis Imperfecta | 000 | 2 | NIH | 4/2/2024 | $175,230 |
|
